The primary objectives of this study are to evaluate the potential for preoperative pharmacogenomics (PGx) testing to positively influence postoperative opioid use through visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores as measured by OBAS in patients undergoing major abdominal surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
10
Post-operative pain management as indicated by pharmacogenomic testing results.
Cleveland Clinic
Cleveland, Ohio, United States
Post-operative opioid use
Post-operative opioid use through visual analog scale guided administration of narcotic equivalent
Time frame: Post-op day 1
Overall Benefit of Analgesia Score (OBAS)
Time frame: Post-op day 1
Length of stay
Time frame: 30 days
Readmission rate
Time frame: 30 days
Functional status
Assessed through Duke Activity Status Index (DASI)
Time frame: 4 weeks and 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.